cryptocurrency most popular Top snippets

Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Morgan Stanley published a research report, predicting that Chow Tai Fook's share price will outperform the market index in the same period in the next 30 days with a 70% to 80% chance, pointing out that Politburo meeting of the Chinese Communist Party revealed a strong stimulus policy tone yesterday, indicating that it is necessary to expand domestic demand, and called for supporting measures for housing and stock market stability, hoping for stable asset prices, which will have a positive impact on gold and jewelry consumption. The bank also pointed out that December of each year to February of the following year is usually the traditional peak season for jewelry sales, and Chow Tai Fook's share price has fallen by about 40% this year, which is inferior to the performance of MSCI China Index and Hang Seng Index in the same period. It is expected that the strength and implementation details of the central government's stimulus measures, the pace of inflation and the stability of gold prices in the future will affect whether the company's valuation can be revalued in the market and maintain its "in sync with the market" rating, with a target price of HK$ 8.3.Xinjiang's revitalization plate rose in a short period of time, Xinjiang Jiaojian had a daily limit, Qingsong Jianhua, Bona Film and Friendship Group had previously closed the board, the western animal husbandry rose by more than 10%, and the western construction, Beixin Road and Bridge, Tianshun shares, Beiken Energy and Guotong shares followed suit.

AUD/USD fell in the short term, and the intraday decline expanded to 0.8%, after the Reserve Bank of Australia announced its interest rate decision.Hongya CNC: The income from exporting products to the US market is relatively low. Hongya CNC (002833) said on the interactive platform today that the company's products are exported to more than 70 countries and regions, and the income from the US market is relatively low.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.

Sichuan Luqiao established a new building materials company, and the enterprise search APP showed that recently, Sichuan Jiaojian Building Materials Co., Ltd. was established, with Qu Hong as the legal representative and a registered capital of 5 million yuan. Its business scope includes: sales of building materials; Non-metallic minerals and products sales; Manufacturing of nonmetallic mineral products; Metal ore sales, etc. Enterprise survey shows that the company is indirectly wholly-owned by Sichuan Luqiao.Australia's S&P/ASX 200 index closed at 8399.40 points, down 0.28%.World Bank: Kenya's growth forecast for 2024 is lowered to 4.7% due to financial challenges.